Substance
IBRUTINIB
Global reference: every product and company linked to this substance.
- cas: 936563-96-1
- ncit: C81934
- pubchem_cid: 24821094
- rxnorm: 1442981
- unii: 1X70OSD4VX
CRA-032765 · ibrutinib [INN] · IBRUTINIB [JAN] · IBRUTINIB [USAN] · Ibrutinib [WHO-DD] · IMBRUVICA · PC-32765 · PCI 32765 · PCI-32765 · PCI-32765-00
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ABBVIE INC. COMMON STOCK | IMBRUVICA | Q2 2026 | $532.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- IBRUTINIB · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- IMBRUVICA · ABBVIE INC. COMMON STOCK